rare diseases English news | rare diseases, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

The Union Health ministry has released Rs 22.20 crore for 134 patients undergoing treatment for rare diseases at eight designated hospitals since the guidelines for providing financial aid to such patients were issued last August.On May 19, the ministry increased the financial support from Rs 20 lakh to Rs 50 lakh for patients belonging to all categories of rare diseases, and on August 11 issued guidelines to grant financial aid to such patients under the National Policy for Rare Diseases, 2021.According to officials, the number of Centres of Excellence (CoEs) designated for treating those with rare diseases like Gaucher Disease, Tyrosinemia, Severe Combined Immunodeficiency (SCID) and others have also been increased from eight to eleven.The 11 CoEs are AIIMS, New Delhi, Maulana Azad Medical College, New Delhi, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Post Graduate Institute of Medical Education and Research, Chandigarh, Centre for DNA Fingerprinting and Diagnostics with Nizam's Institute of Medical Sciences, King Edward Medical Hospital, Mumbai, Institute of Post-Graduate Medical Education and Research, Kolkata, Centre for Human Genetics with Indira Gandhi Hospital, Bengaluru, AIIMS Jodhpur and SAT Hospital, Kerala.The budget allocation for the financial year 2022-2023 for rare diseases was Rs 25 crore. Rest of the 2.80 crore will soon be disbursed for the treatment of rare disease patients, the source said.The guidelines mentions that a maximum financial assistance admissible under the scheme will be up to Rs 50 lakh per patient and the financial assistance per patient will be given to the concerned CoE, where the patient is getting treatment, it said.There are three groups in which patients diagnosed with rare diseases have been classified. Group 1 includes disorders amenable to one-time curative treatment while Group 2 includes diseases requiring long-term lifelong treatment having relatively lower cost of treatment, and the benefit has been documented in literature.Under group 3 falls those diseases for which definitive treatment is available but challenges are to make optimal patient selection for benefit, very high cost and lifelong therapy.

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Marathi Language Controversy

Maharashtra News

Mumbai Local

Weather Update

Mumbai Rains

Ahmedabad Plane Crash

Rare DiseasesFOLLOW

Rare diseases, Latest News

Health :MAL: New Rare Blood Group Discovered After 20 Years of Research

How many years should you spend on discovering something? 5, 10, 15... Researchers from Britain and Israel have spent ... ...

Health :Centre releases Rs 22.20 crore for 134 patients undergoing treatment for rare diseases

The Union Health ministry has released Rs 22.20 crore for 134 patients undergoing treatment for rare diseases at eight ... ...